Newsletter #6 - Mar 2022
A complete team in placeDuring recent months Cessatech, as part of our business progress, have advanced our leadership team, adding important competencies within CMC, Clinical, Regulatory and Business Development in order to progress and secure the full potential of our key asset CT001 Martin has from 14 years CMC with Lundbeck, Etienne a long history with Business Development from Leo Pharma and Nycomed, Louise from from both regulatory consultancy and Orphazyme, and Benedikte with clinical experience from both Novo Nordisk and Zealand PharmaProbably the best small biotech team in